Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of ABEONA THERAPEUTICS INC. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
ABEONA THERAPEUTICS INC. quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • ABEONA THERAPEUTICS INC. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 30 Sep 2025 was $20,358,000, a 33% increase year-over-year.
  • ABEONA THERAPEUTICS INC. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2012 was $10,532,000, a 319% decline from 2011.
  • ABEONA THERAPEUTICS INC. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2011 was $2,515,000, a 67% increase from 2010.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

ABEONA THERAPEUTICS INC. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $20,358,000 +$9,911,000 +33% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $124,345,000 +$116,939,000 +1579% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q3 2024 $30,269,000 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $7,406,000 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2

ABEONA THERAPEUTICS INC. Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2012 $10,532,000 -$8,017,000 -319% 01 Jan 2012 31 Dec 2012 10-K 20 Mar 2013 2012 FY
2011 $2,515,000 +$5,022,000 +67% 01 Jan 2011 31 Dec 2011 10-K 20 Mar 2013 2012 FY
2010 $7,537,000 01 Jan 2010 31 Dec 2010 10-K 23 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.